Robert DeSantis - 28 Feb 2023 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Reporting relationship: EVP & Chief Product Officer
Issuer ticker: ISRG
Reported as of: 28 Feb 2023
Net transaction value: -$391,110
SEC form: 4
Accepted by SEC: 01 Mar 2023, 16:57:42 UTC
Prior SEC filing: 27 Feb 2023
Next SEC filing: 24 Apr 2023
Source filing: View source filing
Reporting owner signature: By: Donna Spinola For: DeSantis, Robert

Key filing fact

Robert DeSantis filed Form 4 for INTUITIVE SURGICAL INC (ISRG) on 01 Mar 2023.

Key facts

This page summarizes Robert DeSantis's Form 4 filing for INTUITIVE SURGICAL INC (ISRG).
8 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 01 Mar 2023, 16:57.

Change

Previous filing in this sequence was filed on 27 Feb 2023.
Current net transaction value: -$391,110.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ISRG transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +2,175
Change %: +29%
Price: $0.000000
Shares after: 9,629
Date: 28 Feb 2023
Ownership: Direct
Footnotes: F1

ISRG transaction

Common Stock

Tax liability

Transaction value: $231,225
Shares: -1,008
Change %: -10%
Price: $229.39
Shares after: 8,621
Date: 28 Feb 2023
Ownership: Direct
Footnotes: F1

ISRG transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +1,504
Change %: +17%
Price: $0.000000
Shares after: 10,125
Date: 28 Feb 2023
Ownership: Direct
Footnotes: F1

ISRG transaction

Common Stock

Tax liability

Transaction value: $159,885
Shares: -697
Change %: -6.9%
Price: $229.39
Shares after: 9,428
Date: 28 Feb 2023
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ISRG transaction Derivative

Non-Qualified Stock Option (right to buy)

Award

Transaction value: $0
Shares: +5,746
Change %
Price: $0.000000
Shares after: 5,746
Date: 28 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,746
Exercise price: $229.39
Footnotes: F2

ISRG transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -2,175
Change %: -50%
Price: $0.000000
Shares after: 2,172
Date: 28 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,175
Exercise price: $0.000000
Footnotes: F3

ISRG transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -1,504
Change %: -25%
Price: $0.000000
Shares after: 4,511
Date: 28 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,504
Exercise price: $0.000000
Footnotes: F3

ISRG transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +3,831
Change %
Price: $0.000000
Shares after: 3,831
Date: 28 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,831
Exercise price: $0.000000
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Footnote F2

12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

Footnote F3

Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.

Footnote F4

Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock upon vesting. 25% of the RSUs shall vest on each anniversary of February 10, 2023, subject to Reporting Person's continuous service to the Issuer through each such vesting date.